IP Library Granted Patent US 9,085,791
Granted Patent B2
US 9,085,791 · App. 13/983,864 · Granted Jul 21, 2015

Method for screening substance relating to endoplasmic reticulum stress participating in onset of diabetes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,085,791
App. No.
13/983,864
Granted
Jul 21, 2015
Kind
B2
Abstract

A system for evaluating activation of the pathway mediated by ATF6. More specifically, a method for screening an endoplasmic reticulum stressor, as well as a method for screening a substance for suppressing an endoplasmic reticulum stress induced by the activation of the pathway mediated by ATF6, and a method for screening an antidiabetic drug candidate. A method for real-time evaluation of activation of the pathway mediated by ATF6 in viable cells. The method uses a polynucleotide encoding a nonfluorescent peptide domain derived from a fluorescent protein and an ATF6 protein domain.

Claims (14)

1. A polynucleotide encoding an amino acid sequence having:

(1) a nonfluorescent peptide domain 1 of a fluorescent protein constituted of a nonfluorescent peptide domain 1 and a nonfluorescent peptide domain 2, characterized in that when nonfluorescent peptide domain 1 and nonfluorescent peptide domain 2 are associated, fluorescent activity is gained; and

(2) an ATF6 protein domain,

wherein the polynucleotide has a region encoding (1) at the 5′ end, a region encoding (2) at the 3′ end, and a region encoding a PEST sequences between the region encoding (1) and the region encoding (2),

wherein the polynucleotide does not encode the fluorescent protein, and

wherein the fluorescent protein is GFP, GFP mutants, or a GFP-like protein family member.

2. The polynucleotide according to claim 1 , wherein the polynucleotide encodes an amino acid sequence in which the nonfluorescent peptide domain 1 of said fluorescent protein and the PEST sequences are connected via a spacer having more than 6 amino acid residues.

3. A transgenic vector comprising the polynucleotide according to claim 1 .

4. A transformed cultured cell comprising a transgenic vector according to claim 3 .

5. The transformed cultured cell according to claim 4 , further comprising a polynucleotide encoding an amino acid sequence having:

(3) the nonfluorescent peptide domain 2 of said fluorescent protein; and

(4) a nuclear localization signal peptide domain,

in a state where a protein having the amino acid sequence having (3) and (4) can be expressed.

6. The transformed cultured cell according to claim 5 , wherein the transformed cultured cell is a pancreatic β-cell.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2019
From: TOKUSHIMA UNIVERSITY
To: ER STRESS RESEARCH INSTITUTE, INC.
Reel/Frame 050516/0912 →
CHANGE OF ENGLISH NAME Recorded Jan 28, 2016
From: THE UNIVERSITY OF TOKUSHIMA
To: TOKUSHIMA UNIVERSITY
Reel/Frame 037630/0710 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2013
From: OYADOMARI, SEIICHI
To: THE UNIVERSITY OF TOKUSHIMA
Reel/Frame 031103/0109 →